AGENDA: DAY II
TUESDAY, JUNE 15, 2021
MORNING MINI SUMMITS
MINI SUMMITS ROUND II
MINI SUMMIT 6
Best Practices in Virtual Investigations10:00 am CET
Introductions, Panel Discussion and Q&A
Keith Burn
Global Investigations Director, Ipsen Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS; Former Detective Constable, London Metropolitan Police, Slough, UK
Robert Ennis, JD, LLM
Vice President and Lead Compliance Counsel, Pfizer New York, NY, USA
Franziska Janorschke
Global Head, Business Practices Office, Novartis International AG, Basel, Switzerland
Anthony McQuillan, LLB
Vice President Legal & Compliance EMEA, Medtronic International, London, UK
Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA (Discussion Coordinator)MINI SUMMIT 7: How to Build and Manage Healthcare Compliance Risk Assessments
10:00 am CET
Introductions, Panel Discussion and Q&A
Ann Beasley, JD
Chief Compliance Officer, Zai Lab; Former Senior Vice President, Chief Compliance Officer, Biogen; Former Global Compliance Office, Novartis Pharma AG, Boston, MA, USA
Anisa Dhalla
Global Chief Compliance Officer, UCB, Inc., Atlanta, GA, USA
Sue Egan
Director and Principal Consultant, Sue Egan Associates; Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
Lauri G. Opar
Head, Enterprise Risk Management & Risk Analytics Global Ethics & Compliance, GlaxoSmithKline Brentford, Middlesex, UK
Sylvie Gallage-Alwis, DEA, LLM
Partner, Signature Litigation Avocat à la Cour Solicitor in England & Wales Committees Vice Chair, International Association of Defense Counsel, Paris, France (Discussion Coordinator)MINI SUMMIT 8: Ethics and Compliance Issues when Interacting with Third Parties
10:00 am CET
Introductions, Panel Discussion and Q&A
Laetitia Ducroquet
Vice President, Global Business Ethics, Ipsen, Boulogne-Billancourt, France
Alex Fell
Head Ethics, Compliance and DPO International, Amicus Therapeutics; Former Vice President, Global Ethics and Compliance, Head of Strategy, Planning and Operations, GlaxoSmithKline, London, UK
Keith Korenchuk, MPH, JD
Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD, USA
Gina Nese, JD
Vice President Global Compliance and Ethics Officer, Align Technology; Former Chief Compliance Officer, Advanced Sterilization Products Bellevue, WA, USA
Mario Prohasky
Principal, EMEA Compliance Consulting Lead, IQVIA, London, UK (Discussion Coordinator)MINI SUMMIT 9: Tech Enablement of Your Global Compliance Program
10:00 am CET
Introductions, Panel Discussion and Q&A
Matt Abrahamson, MBA
Senior Compliance Analyst, DH Diagnostics LLC, a Danaher company, Buffalo Grove, IL, USA
Ethan Gumpert
Global Ethics, Compliance & Governance, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA
Vahan Minassian, JD
Digital Compliance Counsel, Compliance Division, Global Programs, Pfizer, Philadelphia, PA, USA
Sharon Muscato
Director, Compliance Operations, Moderna; Former Director, Transparency & Compliance Operations, Alexion Pharmaceuticals, Inc.; Cambridge, MA
Vanessa Westphal, JD, MS
Head of Compliance Center of Excellence, Merck KGaA, Darmstadt, Germany
Steffen Esche
Director, Consulting, Risk & Regulatory, PwC, Frankfurt, Germany (Discussion Coordinator)11:00 am CET
Transition BreakMINI SUMMITS ROUND III
MINI SUMMIT 10: Challenges and/or Considerations in Maintaining a Methodology in a Fair Market Value (FMV) Analysis
11:15 am CET
Introductions, Panel Discussion and Q&A
Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany
Pascale Schmidt
Chief Compliance Officer and Chair, Corporate Sustainability Committee, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Heidi Teresi
Director, US Ethics & Compliance, Bausch Health; Former Lead, Education and Communication, US Compliance and Ethics, Bristol-Myers Squibb, Princeton, NJ
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Raleigh-Durham, NC, USA (Discussion Coordinator)MINI SUMMIT 11: Ethics and Compliance Considerations for Gene Therapy and Ultra Rare Disease Products
11:15 am CET
Introductions, Panel Discussion and Q&A
Sandra González, JD
Senior Associate, Life Sciences and Healthcare Practice Group, Paul Hastings, New York, NY, USA
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Social Responsibility Officer, Ipsen Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Former Compliance Director Western Europe & Canada, AbbVie, Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France
Steve Vincze, JD, LLM, MBA
President and Chief Executive Officer, TRESTLE Compliance, LLC; Former Senior Vice President and US Chief Compliance Officer, Privacy Officer and Senior Legal Counsel; Former Vice President, Ethics & Compliance Officer, TAP Pharmaceuticals, Boston, MA, USA
Oscar Perdomo
Director, Pharmaceutical & Life Sciences, Advisory Services, PwC Switzerland, Zurich, Switzerland (Discussion Coordinator)MINI SUMMIT 12: GDPR and the Tumultuous World of Data Privacy
11:15 am CET
Introductions, Panel Discussion and Q&A
Stefano Biondi, LLB, PhD
Compliance Manager and Group Data Protection Officer, Menarini Group, Florence, Italy
Rika De Ville
Vice President Global Compliance, Privacy & Data Protection Officer, Perrigo Company plc, Nazareth, Belgium
Ariadna Quesada, MSJ
Compliance Director Europe and MEATI, Hillrom; Former Law, Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Manager International, MicroPort Orthopedics, Amsterdam, Netherlands
Giuseppe Saporito, LLM
Global Legal & Regulatory Expert, IQVIA, Milan, Italy
Elisabeth Kohoutek
Senior Associate, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany (Discussion Coordinator)MINI SUMMIT 13: Ethics and Compliance Issues in Patient Relationships, Including Patient Access and Support
11:15 am CET
Introductions, Panel Discussion and Q&A
Duygu Beyazo, LLB
Senior Associate, NSN Law Firm Former Compliance Manager (Secondment), Business Conduct, Gilead Sciences, Istanbul, Turkey
Martin Eschbach, JD
Head Ethics, Risk and Compliance and Legal Patient Engagement, Novartis International AG, Baden-Württemberg, Germany
Larisa K. Jasnic, LLB, LLM
Head of Ethics & Compliance, International, Alnylam Pharmaceuticals; Former Regional Compliance Officer, Region Europe, Novartis, Zug, Switzerland
Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics; Ethics and Compliance Lecturer, SciencesPo; Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Former Compliance Director Western Europe & Canada, AbbVie; Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Atlanta, GA, USA (Discussion Coordinator)12:15 pm CET
Luncheon Break/Visit Exhibit Hall
Day II Plenary Session
1:00 pm CET
Introduction to Global Anticorruption Landscape: Government Enforcement
Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, GA, USA (Session Moderator)1:05 pm CET
EU Public Prosecutor's Office (EPPO) Update
Anna-Elisabeth Krause-Ablass, JD
European Delegated Prosecutor, European Public Prosecutor's Office; Former Specialized Public Prosecutor for White Collar Crime Frankfurt, Frankfurt, Germany
Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany (Discussion Coordinator)1:25 pm CET
Agence Française Anti-corruption (AFA) Update
Clément Grospiron
Mission Head to the Chief Supervision Directorate, Agence Française Anti-corruption (AFA), Paris, France
George Fife
Partner, Forensic & Integrity Services, EY, Paris, France (Discussion Coordinator)1:45 pm CET
UK Serious Fraud Office Update
Judy Krieg, JD
Head of Fraud, Bribery and Corruption, Division B, UK Serious Fraud Office; Former Chief Compliance Officer, Rolls-Royce plc, London, UK2:05 pm CET
OECD Anti-bribery Update
Gemma Aiolfi
Head of Compliance, Corporate Governance and Collective Action, Basel, Switzerland2:35 pm CET
US FCPA and European Enforcement Update
Nicola Bonucci, MA, DEA, DESS
Partner, Global Trade and Investigations & White Collar Defense, Paul, Hastings; Former Director of Legal Affairs, Organisation for Economic Cooperation and Development's (OECD), Paris, France
David Fuhr, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC, USA
Eugenio Fusco
Deputy Attorney at the Court, Public Prosecutor at the Court of Milan, Milan, Italy
Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA (Discussion Coordinator)3:15 pm CET
Transition Break3:30 pm CET
China Update
Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China3:45 pm CET
LATAM Update
Imelda Álvarez, LLB, MBA
Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis, Mexico City, Mexico4:00 pm CET
Global Anticorruption Roundtable
Imelda Álvarez, LLB, MBA
Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis, Mexico City, Mexico
Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany
George Fife
Partner, Forensic & Integrity Services, EY, Paris, France
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division; Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice, Washington, DC, USA
Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China